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(Fig. 1a), which is in line with a recent study by Atanasio 
et al. [1] who report, but do not specify, decreased sur-
vival rates. In line with our previous observations [3], full 
C9orf72 ablation results in a 5.9 % decrease in body weight 
(P = 0.0056), without affecting motor function (accel-
erating rotarod and grip strength test) or inducing patho-
logical hallmarks of ALS (see also [1, 2]), such as motor 
neuron degeneration, gliosis, enhanced ubiquitination and 
TDP-43 mislocalization. However, post-mortem analysis 
of full C9orf72 knockout mice (n = 5; 11–15 months of 
age) revealed enlarged lymph nodes (LNs) (n = 4 mice) 
and splenomegaly (n = 5) (Fig. 1b). Detailed histological 
evaluation detected massive infiltration of histiocytes/mac-
rophages and lymphocytes in multiple organs, including 
LNs, spleen, bone marrow, liver, kidney and lung (Fig. 1c–
k). In addition to these immunological phenotypes, which 
are in part also reported by Atanasio et al. [1] and O’Rourke 
et al. [2], we detect evidence of neoplastic events. LNs 
of several animals (n = 4) contained infiltrates of B220/
CD45R-positive B-lymphocytes that disrupted tissue archi-
tecture and were accompanied by increased expression of 
the proliferation marker Ki67, suggesting the development 
of B-cell lymphomas (Fig. 1c–e). Furthermore, disrupted 
tissue architecture and homogeneous populations of F4/80-
positive macrophages expressing Ki67 were present in LNs 
(n = 3), spleen (n = 3), liver (n = 1) and lung (n = 1). 
Moreover, infiltrating cells in the liver and lung accumu-
lated in intravascular spaces (Fig. 1f–k), suggesting the 
occurrence of metastatic histiocytic sarcomas. These results 
indicate that the defects in immune cell function recently 
reported in C9orf72 knockout mice (e.g. changes in endo-
some/lysosomal trafficking, cytokine production) [1, 2] 
may ultimately lead to neoplastic events in multiple organs. 
These findings have important implications as they indicate 
that strategies aimed at lowering systemic C9ORF72 levels 
Non-coding hexanucleotide (GGGGCC) repeat expan-
sions in C9ORF72 are the most common genetic cause of 
amyotrophic lateral sclerosis (ALS) and frontotemporal 
dementia (FTD; C9ALS/FTD). Decreased C9orf72 pro-
tein levels in C9ALS/FTD patients [4] support the idea that 
C9ORF72 haploinsufficiency may contribute to disease 
pathogenesis. To test this hypothesis, we previously gener-
ated and analyzed neural-specific C9orf72 knockout mice. 
Our results showed that neural-specific ablation of C9orf72 
(3110043O21Rik) in mice does not cause motor neuron 
degeneration or changes in motor function [3]. We there-
fore concluded that loss of C9ORF72 on its own is unlikely 
to cause ALS and that reducing C9ORF72 levels may com-
prise a promising strategy to treat C9-ALS patients. This 
therapeutic potential led us, and others [1, 2], to subse-
quently analyze knockout mice lacking C9orf72 in all tis-
sues. Importantly, in contrast to our previous report, we 
find that full ablation of C9orf72 induces reduced survival 
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in C9ALS/FTD patients may have negative side effects and 
that emphasis should be on therapeutic approaches that 
selectively target the hexanucleotide repeat expansions or 
their downstream pathogenic effects.
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Fig. 1  C9orf72 knockout mice display reduced survival, immune 
system-related pathology and neoplastic events. a Kaplan–Meier 
curves show survival rates corrected for gender and body weight. 
C9orf72 knockout mice show reduced survival as compared to litter-
mate controls (Hazard ratio = 19.0; 95 %, CI: 2.4–150.2, P = 0.005). 
Wild-type controls n = 24; C9orf72 knockout n = 29. b Gross image 
showing enlarged lymph nodes (LNs; black arrows) and spleno-
megaly (white arrow) in a C9orf72 knockout mouse (12 months of 
age). c–e B-cell lymphoma in the submandibular LNs of C9orf72 
knockout mouse. Nodal tissue is effaced by a monotypic cell popula-
tion composed of B220/CD45R-positive lymphocytes (B cells). Note 
the high proliferation rate of the neoplastic lymphocytes as indicated 
by immunostaining for Ki67 (proliferation marker). f–h Histiocytic 
sarcoma in the liver of C9orf72 knockout mouse. Hepatic sinusoids 
are filled with atypical histiocytes and multinucleated giant cells that 
stain positive for the macrophage lineage marker F4/80 and exhibit 
a high proliferation rate, as evidenced by Ki67 immunostaining. i–k 
Histiocytic sarcoma in lung vasculature in C9orf72 knockout mouse. 
Pulmonary blood vessels are filled with atypical and multinucleated 
giant cells that immunostain for F4/80 and Ki67. H&E hematoxylin 
and eosin. Scale bar 1.3 cm (b), 65 μm (c), 40 μm (d–h), 125 μm 
(i), and 90 μm (j, k)
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